- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 27-02-2026: General Updates
27-02-2026 | 04:09 pm
27-02-2026 | 04:09 pm
US FDA inspected Aurobindo Pharma's subsidiary Eugia Pharma's Unit-I, concluding with 4 observations. The company confirms no impact on its financials or operations.
No comments yet. Be the first to comment!